Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Serum Albumin from Oryza sativa vs Human Albumin in Decompensated Cirrhosis Ascites
CTR20210984Phase 2Completed
- Sponsor
- Healthgen Biotech
- Start
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of albumin (human) in Cirrhosis, ascites, sponsored by Healthgen Biotech. Started May 2021; status: completed.
02
Drugs
albumin (human)
03
Conditions
Cirrhosisascites
Beyond the preview
Go deeper on CTR20210984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210984.